Global Search

Search articles, concepts, and chapters

Casale Ralph A

๐Ÿ‡ด๐Ÿ‡ฒ Entegris (United States)
OpenAlex2 articles in GJC

2 articles in GJC

1.

Preclinical Evaluation of Safety and Efficacy of QLS-111: A Novel Formulation of an Adenosine Triphosphate-Sensitive Potassium Channel Opener.

Wirostko Barbara M, Roy Chowdhury Uttio, Brandano Lisa A, Casale Ralph A, DeWalt Daniel J, Rykard Laura R et al.

Ophthalmol SciFeb 20260 citationsBasic Science

QLS-111, a novel potassium channel opener, safely and effectively lowered eye pressure in animals, showing additive benefits with existing glaucoma drugs by reducing episcleral venous pressure, promising a new treatment.

2.

Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug.

Pervan-Steel Cynthia L, Roy Chowdhury Uttio, Sookdeo Hemchand K, Casale Ralph A, Dosa Peter I, Htoo Thurein M et al.

Invest Ophthalmol Vis SciApr 20220 citationsBasic Science

QLS-101, a novel prodrug, effectively lowered eye pressure in mice for 24 hours after daily topical application, converting to its active form in human eye tissues. This offers a new glaucoma treatment.

All 2 articles loaded